Alvogen, Inc. recalled Levothyroxine Sodium Tablets on January 21, 2026, after a pharmacy reported a mix-up with dosages. Some bottles contained 88 mcg tablets instead of the prescribed 150 mcg. The recall affects 1,000 tablets from lot # MHA21825, with an expiration date of December 31, 2027.
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Alvogen, Inc or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Levothyroxine Sodium Tablets are commonly prescribed to treat thyroid hormone deficiency. They help regulate metabolism and maintain energy levels in patients with hypothyroidism.
This recall stems from a product mix-up where a bottle containing 88 mcg tablets was mistakenly labeled as containing 150 mcg tablets. Taking the incorrect dosage can significantly impact patient health.
This recall is not part of a broader industry pattern.
The recall poses a significant risk to patients relying on the specific dosage of Levothyroxine Sodium. Consumers should act quickly to address the recall.
The lot number can typically be found on the label or bottom of the bottle.
Expect a refund or replacement processing time of approximately 4-6 weeks.
Keep records of all communications with Alvogen, including dates and details of your inquiries.
The recall includes Levothyroxine Sodium Tablets, USP, 150 mcg, in bottles of 1,000 tablets. These were manufactured by LLOYD, Inc. in Shenandoah, IA, and distributed by Alvogen, Inc. in Pine Brook, NJ.
Only one incident of product mix-up has been reported, affecting a single bottle. There are no additional reported injuries or health complications at this time.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.
ZOLIQUEX recalled adult portable bed rails sold on Amazon after reports of entrapment and asphyxiation risk. The recall targets silver bed rails measuring 12.4 inches wide by 33.07 inches tall and weighing 7.1 pounds. The model numbers ZEX014-V1 and the Zoliquex branding appear on packaging. Stop using the product and seek a full refund by contacting ZOLIQUEX.
Vitaquest International recalled Arey Not Today iron supplements sold at retailers nationwide after determining the products do not meet the Poison Prevention Packaging Act's child-resistant packaging requirement. The noncompliant packaging creates a poisoning risk to young children if ingested. Consumers should stop using the products immediately and contact Vitaquest for a free child-resistant替换
Easymake adult portable bed rails imported by ZFZG-US are recalled on April 9, 2026. The recall cites a risk of entrapment and asphyxiation and notes the product lacks required hazard warning labels. Stop using the recalled rails immediately and contact ZFZG-US for a full refund.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Tuymec Minoxidil Hair Growth Kit sold on Amazon by DrHealBeauty is recalled for non-child-resistant packaging. The kit contains two black spray bottles with 5% minoxidil and BIOTIN labels. Consumers should stop using the product immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure.
TecFlox recalled its Minoxidil Topical Solution hair growth serum bottles on April 2, 2026. The packaging is not child-resistant, violating the Poison Prevention Packaging Act. Consumers should stop using the product immediately, store it out of reach of children, and email TecFloxrecall@outlook.com to receive free replacement bottles. Only bottles with serum remaining will be replaced; dispose of